全球心血管药物研发动态摘要.pdfVIP

Ch inese Jou rnal of N ew Drugs 20 10, 19 ( 1) , ( 中国药科大学, 南京 210009) [] 在全球范围内, 心血管疾病仍然是死亡的元凶因此从流 病学角度看, 心血管疾病是公共 卫生关注的重要领域文中从心血管疾病的现状心血管药物市场分析心血管药物研发现状等方面对全球 心血管药物研究的全景进 了详尽分析, 分析了当前心血管药物研发领域更具挑战的环境, 如重要产品的溃 败以及研发面临的困难等, 同时也指出尽管研发环境不容乐观, 心血管疾病治疗领域仍然是最可获利的市场 领域, 通过开发独特创新机制药物采用新技术以及开发新的复方制剂, 心血管药物的开发前景仍然十分广 阔另外, 还对心血管药物几个重大领域( 抗凝剂抗动脉粥样硬化药物抗高血压药抗心力衰竭药抗心 绞痛药抗心律失常药) 的最新研发动态及重要的在研药物进 了综述 [] 心血管药物; 研究开发; 市场分析 [] R 972 [ ] C [] 1003- 3734 ( 2010) 0 1- 000 8- 09 Progress in global research and developm ent of cardiovascular m edicines CH EN L ing, ZOU X u ( Ch ina Pharm aceutical Un iv ers ity, N anj ing 210009, Ch ina ) [Abstract] G loba lly, card iovascu lar disease ( CVD ) k ills m ore p eop le th an any other d iseases. T here fo re, ep idem io log ical consideration s m ean th at CVD w ill rem ain an mi portant area of public hea lth concern in the m a in ph arm aceutica lm arkets. T he p anoram a of the cardiovascular m ed icinesw as thoroughly analyzed concern ing the sta tu s quo, m arketing analysis and R D actu ality. D esp ite o f the m ore cha lleng ing env ironm ent, severa lm ajor p layers seem to con sider th at the CVD m arket still includes areas of mi portan t unm et need. M eanwh ile, the latest progress in the m ajor fields of CVD, such as antic lo tt ing agents, atherosclerosis, hyp ertension, heart failure, ang ina, anti arrhythm ic drugs, and the key develop ing drugs in developm ent w ere rev iew ed in th is paper as w e l.l [K ey words] card iovascu lar m edic ines; research and developm ent; m arket ing analysis 1 760 , 11 , [